Fri, August 6, 2021
Thu, August 5, 2021
Wed, August 4, 2021
Tue, August 3, 2021
Mon, August 2, 2021

Geoffrey Porges Maintained (TBPH) at Buy with Increased Target to $37 on, Aug 4th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-37-on-aug-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $36 to $37 on, Aug 4th, 2021.

Geoffrey has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoffrey


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021

Publication Contributing Sources